ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk readies to bring weight-loss drug Wegovy to India
Danish pharmaceutical company Novo Nordisk is set to launch its anti-diabetes and weight-loss drug Wegovy in India, aiming to outperform Eli Lilly's Mounjaro. Regulatory approval for Wegovy's cardiovascular benefits has been granted, pending final approval
Announcement as on 07 April 2025

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today
Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The decliners were Novo Nordisk (NYSE: NVO), famously the company behind Wegovy, and Viking Therapeutics (NASDAQ: VKTX), which is far along in
Announcement as on 11 February 2025

What's Happening With Novo Nordisk Stock?
Novo Nordisk ADR (NYSE: NVO) currently trades at per share, more than 40% below its peak level of over 5 seen in June of this year. In contrast, its closest peer, Eli Lilly stock (NYSE:LLY) is down 15% over this period. NVO stock was trading around
Announcement as on 26 December 2024

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India is urging the company to launch its popular weight-loss drug, Wegovy, next year to stay ahead of rival Eli Lilly. Concerns have been raised about Novo potentially lagging behind if Wegovy is not introduced before Lilly's drug,
Announcement as on 03 December 2024

Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India
Novo Nordisk is broadening its Bengaluru operations by increasing senior leadership, doubling global process leaders in India, and boosting headcount by 16% next year. The company is also collaborating with Indian AI startups to improve efficiency, particu
Announcement as on 11 October 2024

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 49.77
  • 12Day Average: 48.44
  • 20Day Average: 48.16
  • 50Day Average: 50.74
  • 100Day Average: 53.28
  • 150Day Average: 58.8
  • 200Day Average: 61.85

NVO Indicators & signals

Indicator MACD (12,26,9)

48.81, 48.98, -0.63
Indicator MACD is in negative zone

Indicator ADX (14)

9.47, 24.86, 30.06
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Tue Dec 2025 48.96 48.41 to 49.97 -2.8% 1.13 times
15 Mon Dec 2025 50.37 49.55 to 50.66 0.38% 0.91 times
12 Fri Dec 2025 50.18 49.92 to 50.75 -0.22% 0.99 times
11 Thu Dec 2025 50.29 49.59 to 50.54 2.53% 1.25 times
10 Wed Dec 2025 49.05 47.04 to 49.50 5.8% 1.36 times
09 Tue Dec 2025 46.36 46.08 to 46.79 -0.88% 0.82 times
08 Mon Dec 2025 46.77 46.35 to 47.17 -2.26% 1.19 times
05 Fri Dec 2025 47.85 47.83 to 49.15 -0.29% 0.72 times
04 Thu Dec 2025 47.99 46.84 to 48.24 0.88% 1.08 times
03 Wed Dec 2025 47.57 47.30 to 48.11 0.27% 0.92 times
02 Tue Dec 2025 47.44 47.37 to 48.87 -2.04% 0.76 times
01 Mon Dec 2025 48.43 48.37 to 49.49 -1.86% 0.93 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top